Windlas Biotech Limited (WINDLAS) reports Q1FY27 results with 18% YoY revenue growth to Rs 248 crore, EBITDA up 26%, and PAT up 37%.
Windlas Biotech Limited (WINDLAS) reports Q4 & FY26 results with 18% YoY revenue growth, Rs. 31.60 EPS, and strong net liquidity.